Intrinsic Value of S&P & Nasdaq Contact Us

McKesson Corporation MCK NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
$1,623.29
+88.1%
Analyst Price Target
$982.38
+13.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

McKesson Corporation (MCK) trades at a trailing P/E of 24.7, forward P/E of 22.1. Trailing earnings yield is 4.05%, forward earnings yield 4.52%. PEG 1.66.

Criteria proven by this page:

  • VALUE (51/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 22.1 (down from trailing 24.7) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 1.66 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 4.05% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.52% as earnings recover.
  • Analyst consensus target $982.38 (+13.9% upside) — modest upside expected.

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
~
VALUE
51/100
Price-to-Earnings & upside
Proven by this page
FUTURE
82/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
55/100
→ Income
GROWTH
90/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — MCK

Valuation Multiples
P/E (TTM)24.7
Forward P/E22.1
PEG Ratio1.66
Forward PEG0.43
P/B Ratio-82.63
P/S Ratio0.27
EV/EBITDA17.5
Per Share Data
EPS (TTM)$35.23
Forward EPS (Est.)$39.02
Book Value / Share$-0.80
Revenue / Share$3,230.18
FCF / Share$81.95
Yields & Fair Value
Earnings Yield4.05%
Forward Earnings Yield4.52%
Dividend Yield0.36%
SharesGrow IV$1,623.29 (+88.1%)
Analyst Target$982.38 (+13.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 16.0 0.30 4.05 0.19 0.67%
2017 6.3 0.05 2.95 0.17 0.77%
2018 437.3 -4.44 2.99 0.14 0.89%
2019 686.1 -14.64 2.88 0.11 1.25%
2020 27.2 0.01 4.81 0.11 1.20%
2021 -6.9 0.01 -1,491.59 0.13 0.88%
2022 41.9 -0.33 -20.52 0.18 0.59%
2023 14.1 0.06 -27.05 0.18 0.58%
2024 23.8 -2.23 -36.26 0.23 0.44%
2025 26.0 1.77 -41.34 0.24 0.40%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $9.70 $190.88B $2.26B 1.2%
2017 $22.73 $198.53B $5.07B 2.6%
2018 $0.32 $208.36B $67M 0%
2019 $0.17 $214.32B $34M 0%
2020 $4.95 $231.05B $900M 0.4%
2021 $-27.02 $238.23B $-4.34B -1.8%
2022 $7.23 $263.97B $1.11B 0.4%
2023 $25.04 $276.71B $3.56B 1.3%
2024 $22.39 $308.95B $3B 1%
2025 $25.72 $359.05B $3.3B 0.9%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $39.02 $38.44 – $39.17 $408.57B $406.68B – $411.94B 9
2027 $44.26 $41.88 – $44.98 $442.22B $438.69B – $446.39B 9
2028 $50.00 $49.01 – $51.43 $478.43B $477.36B – $479.51B 3
2029 $57.69 $57.21 – $58.16 $512.87B $511.56B – $514.18B 2
2030 $67.19 $65.45 – $68.97 $550.69B $539.74B – $561.93B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message